Drug Industry Incentives Out Of DSHEA Purview - Pharmanex Brief
This article was originally published in The Tan Sheet
Executive Summary
Protection of research incentives for prescription drug manufacturers was not an objective of Congress when it drafted the Dietary Supplement Health & Education Act, Pharmanex contends in an Aug. 23 brief to the Salt Lake City federal court. The argument was submitted by the Cholestin marketer in response to FDA's July 20 brief for appeal.